Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients
Clinical trial NCT05463224 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05463224
- Sponsor
- Sehhoon Park
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-04
- Primary completion
- 2026-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.